Literature DB >> 22941415

[Treatment of complications after arteriovenous access surgery].

H Scholz1.   

Abstract

The choice of potential options for an arteriovenous (AV) access is limited for each individual patient. Complications shorten the maximum life span of any AV access. This paper stresses the importance of recognizing complications in time so as to initiate early and adequate therapy which are explained in further detail. Existing vascular accesses should be used as long as possible while maintaining further alternatives for future AV access surgery.

Entities:  

Mesh:

Year:  2012        PMID: 22941415     DOI: 10.1007/s00104-012-2305-y

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  9 in total

Review 1.  Intimal hyperplasia and hemodynamic factors in arterial bypass and arteriovenous grafts: a review.

Authors:  Hiroaki Haruguchi; Satoshi Teraoka
Journal:  J Artif Organs       Date:  2003       Impact factor: 1.731

2.  Vascular changes at the puncture segments of arteriovenous fistula for hemodialysis access.

Authors:  Ju-Feng Hsiao; Hsin-Hua Chou; Lung-An Hsu; Lung-Sheng Wu; Chih-Wei Yang; Tsu-Shiu Hsu; Chi-Jen Chang
Journal:  J Vasc Surg       Date:  2010-07-29       Impact factor: 4.268

Review 3.  Vascular access thrombosis: etiology and prevention.

Authors:  M Brattich
Journal:  ANNA J       Date:  1999-10

4.  Intradialytic hypotension and vascular access thrombosis.

Authors:  Tara I Chang; Jane Paik; Tom Greene; Manisha Desai; Fritz Bech; Alfred K Cheung; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2011-08       Impact factor: 10.121

5.  Incidence and management of seroma after arteriovenous graft placement.

Authors:  Danielle M Dauria; Pawel Dyk; Paul Garvin
Journal:  J Am Coll Surg       Date:  2006-08-24       Impact factor: 6.113

6.  Arterioarterial prosthetic loop: a new approach for hemodialysis access.

Authors:  Juergen Zanow; Ulf Kruger; Michael Petzold; Karen Petzold; Helga Miller; Hans Scholz
Journal:  J Vasc Surg       Date:  2005-06       Impact factor: 4.268

7.  Treatment of perigraft seroma in expanded polytetrafluoroethylene grafts by sequential fibrin sealing of the outer graft surface.

Authors:  Juergen Zanow; Ulf Kruger; Utz Settmacher; Hans Scholz
Journal:  Ann Vasc Surg       Date:  2010-08-30       Impact factor: 1.466

8.  The isolation of a fibroblast growth inhibitor associated with perigraft seroma.

Authors:  S S Ahn; D E Williams; D A Thye; K Q Cheng; D A Lee
Journal:  J Vasc Surg       Date:  1994-08       Impact factor: 4.268

Review 9.  Management of hemodialysis access infections.

Authors:  Sean V Ryan; Keith D Calligaro; Matthew J Dougherty
Journal:  Semin Vasc Surg       Date:  2004-03       Impact factor: 1.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.